================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-A


                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                    PURSUANT TO SECTION 12(b) OR 12(g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                             LORUS THERAPEUTICS INC.
           ----------------------------------------------------------
           (Exact name of the Registrant as specified in its charter)


             ONTARIO, CANADA                                 N/A
- ----------------------------------------    ------------------------------------
(State of incorporation or organization)    (I.R.S. Employer Identification No.)


2 MERIDIAN ROAD, TORONTO, ONTARIO, CANADA                  M9W 4Z7
- -----------------------------------------                ----------
(Address of principal executive offices)                 (Zip Code)


If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. [X]

If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. [ ]

Securities Act registration statement file number to which this form relates:
None

Securities to be registered pursuant to Section 12(b) of the Act:

       Title of Each Class                  Name of Each Exchange on Which
       To be so Registered                  Each Class is to be Registered
- --------------------------------            ------------------------------

Common Shares, without par value               American Stock Exchange


        Securities to be registered pursuant to Section 12(g) of the Act:

                                      NONE
                                ----------------
                                (Title of Class)


================================================================================




                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

ITEM 1.   DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.

This Registrant Statement relates to the Common Shares, without par value, of
the registrant. A complete description of the Common Shares is set forth in the
Registration Statement on Form 20-F of the registrant, filed by the registrant
in December 1991 under the Securities Exchange Act of 1934. By this reference,
such description is incorporated herein and made a part hereof.

ITEM 2.   EXHIBITS.

None.


- --------------------------------------------------------------------------------


                                    SIGNATURE

     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereto duly authorized.



                                          LORUS THERAPEUTICS INC.


                                          By: /s/ Shane A. Ellis
                                              ------------------------------
                                          Name:   Shane A. Ellis
                                          Title:  V.P., Legal Affairs and
                                                  Corporate Secretary


Dated: February 16, 2004